Portal Biotech Closes $35M Series A to Deliver First Full-Length Single-Molecule Protein Sequencer. Breakthrough proteomics platform technology unlocks full-length protein sequencing and characterisation, accelerating drug development & diagnostics. tinyurl.com/5y9cjbej #proteomics #nanopore

“The most important applications of protein sequencing will be the ones we have no idea about today”. Giovanni Maglia founder of Portal Biotech and keynote speaker of #RNGS25, during a chat with our flying reporter Sarah Geurs, Technology Expert at the VIB Tech Watch Core! prez.ly/Zmid